PMID- 14751507 OWN - NLM STAT- MEDLINE DCOM- 20040308 LR - 20190708 IS - 0360-3016 (Print) IS - 0360-3016 (Linking) VI - 58 IP - 2 DP - 2004 Feb 1 TI - Influence of hypoxia on TRAIL-induced apoptosis in tumor cells. PG - 386-96 AB - PURPOSE: Tumor hypoxia reduces the efficacy of radiotherapy, many types of chemotherapy, and tumor necrosis factor-alpha (TNF-alpha). TRAIL (TNF-alpha-related apoptosis-inducing ligand) is a ligand for death receptors of the TNF superfamily shown to be selectively toxic for tumor cells and thereby a promising antineoplastic tool. The impact of hypoxia on TRAIL-induced apoptosis was examined in this study. METHODS AND MATERIALS: Apoptosis induction and growth rates of various tumor cell lines under hypoxia were evaluated in vitro. Biologically effective induction of hypoxia was verified by determination of hypoxia-inducible factor-1 (HIF-1) activation. The efficacy of TRAIL- and radiation-induced apoptosis under different oxygen conditions was quantified in vitro. The impact of Bcl-2 on TRAIL-induced apoptosis under hypoxia or normoxia was evaluated by comparing cells expressing Bcl-2 with a vector control. RESULTS: Moderate hypoxia caused no growth retardation or apoptosis, but led to activation of HIF-1 as a prerequisite of hypoxic gene induction. Cellular responses to TRAIL differed considerably among the cell lines tested. Hypoxia reduced radiation-induced, but not TRAIL-induced, apoptosis in the tested cell lines. Hypoxia did not induce Bcl-2 expression. Bcl-2 had a minor impact on the efficacy of TRAIL-induced apoptosis. CONCLUSION: Taken together, the data indicate that TRAIL is clearly effective under conditions of proven hypoxia. FAU - Weinmann, Martin AU - Weinmann M AD - Department of Radiation Oncology, University of Tubingen, Hoppe-Seylerstrasse 3, 72076 Tubingen, Germany. FAU - Marini, Patrizia AU - Marini P FAU - Jendrossek, Verena AU - Jendrossek V FAU - Betsch, Angelika AU - Betsch A FAU - Goecke, Barbara AU - Goecke B FAU - Budach, Wilfried AU - Budach W FAU - Belka, Claus AU - Belka C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Int J Radiat Oncol Biol Phys JT - International journal of radiation oncology, biology, physics JID - 7603616 RN - 0 (Antineoplastic Agents) RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (DNA-Binding Proteins) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Membrane Glycoproteins) RN - 0 (Nuclear Proteins) RN - 0 (Proteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (TNF-Related Apoptosis-Inducing Ligand) RN - 0 (TNFSF10 protein, human) RN - 0 (Transcription Factors) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9007-49-2 (DNA) RN - EC 3.4.22.- (CASP8 protein, human) RN - EC 3.4.22.- (Caspase 8) RN - EC 3.4.22.- (Caspases) SB - IM MH - Antineoplastic Agents/*pharmacology MH - Apoptosis/*physiology MH - Apoptosis Regulatory Proteins MH - Caspase 8 MH - Caspases/metabolism MH - Cell Hypoxia/*physiology MH - Cell Line, Tumor/drug effects/radiation effects MH - Cell Nucleus/metabolism MH - DNA/metabolism MH - DNA-Binding Proteins/*metabolism MH - Drug Screening Assays, Antitumor MH - Enzyme Activation MH - Humans MH - Hypoxia-Inducible Factor 1 MH - Hypoxia-Inducible Factor 1, alpha Subunit MH - Jurkat Cells/drug effects/radiation effects MH - Membrane Glycoproteins/*pharmacology MH - Nuclear Proteins/*metabolism MH - Proteins/metabolism MH - Proto-Oncogene Proteins c-bcl-2/metabolism MH - TNF-Related Apoptosis-Inducing Ligand MH - *Transcription Factors MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 2004/01/31 05:00 MHDA- 2004/03/09 05:00 CRDT- 2004/01/31 05:00 PHST- 2004/01/31 05:00 [pubmed] PHST- 2004/03/09 05:00 [medline] PHST- 2004/01/31 05:00 [entrez] AID - S0360301603019916 [pii] AID - 10.1016/j.ijrobp.2003.09.052 [doi] PST - ppublish SO - Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):386-96. doi: 10.1016/j.ijrobp.2003.09.052.